{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": "International Business", "byline": {"original": "By JONATHAN WEISMAN", "person": [{"rank": 1, "role": "reported", "firstname": "Jonathan", "organization": "", "lastname": "WEISMAN"}]}, "abstract": "Pharmaceuticals have emerged as possibly most divisive issue amid negotiations over Trans-Pacific Partnership, with activists pushing for access to low-cost drugs and Republicans demanding strong patent protections for industry; passionate arguments highlight trade agreement's complexity, with United States patents raising particularly thorny issues. ", "type_of_material": "News", "word_count": "1053", "lead_paragraph": "No issue in negotiations over a Trans-Pacific Partnership seems to elicit more passion than pharmaceuticals, with both sides using the language of life and death.", "pub_date": "2015-07-31T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Patent Protection for Drugs Puts Pressure on U.S. in Trade Talks", "print_headline": "Drug Patents Are a Hurdle for the U.S. in Trade Talks"}, "snippet": "No issue in negotiations over a Trans-Pacific Partnership seems to elicit more passion than pharmaceuticals, with both sides using the language of life and death.", "multimedia": [{"height": 126, "url": "images/2015/07/31/business/31trade-web1/31trade-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/07/31/business/31trade-web1/31trade-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/07/31/business/31trade-web1/31trade-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/07/31/business/31trade-web1/31trade-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/07/31/business/31trade-web1/31trade-web1-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/07/31/business/31trade-web1/31trade-web1-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/07/31/business/international/pacific-trade-deal-drugs-patent-protection.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Trans-Pacific Partnership", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "International Trade and World Market", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Inventions and Patents", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "United States", "name": "glocations"}, {"rank": "6", "is_major": "N", "value": "Froman, Michael B", "name": "persons"}], "blog": [], "_id": "55ba0afd38f0d810f5649550", "source": "The New York Times"}